Please login to the form below

Not currently logged in
Email:
Password:

dimethyl fumarate

This page shows the latest dimethyl fumarate news and features for those working in and with pharma, biotech and healthcare.

New intramuscular administration for Biogen’s MS therapy Plegridy approved in the EU

New intramuscular administration for Biogen’s MS therapy Plegridy approved in the EU

Biogen’s MS franchise also includes its oral therapy Tecfidera (dimethyl fumarate), although the cmpany has been facing patent challenges to the drug recently.

Latest news

More from news
Approximately 11 fully matching, plus 51 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2017 Deal Watch January 2017

    Biogen. Patent settlement. Tecfidera (dimethyl fumarate). 1, 250. Merrimack Pharamceuti-cals. Ipsen.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Executive vice president of Biogen leaves Executive vice president of Biogen leaves

    Kingsley joined Biogen in 2010 as senior VP and during his tenure Biogen introduced five new therapies including successfully launching Tecfidera (dimethyl fumarate) – the most prescribed oral treatment for multiple sclerosis.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics